How Syngene helped Panbela achieve shorter production time for its pancreatic cancer drug
Learn how Syngene streamlined the production process of Panbela’s pancreatic cancer drug, SBP-101, while ensuring high chiral purity of 98% during GMP manufacturing
Chemistry process research lab for Drug Discovery
Syngene’s Chemistry process research lab acts as a bridge between drug discovery and development when faster delivery of chemical compounds is required – mg to kg.
SynVantage AI-enhanced relay-based drug discovery for optimizing Design-Make-Test-Analyze (DMTA) cycle
SynVantage is Syngene’s platform that enables a continuous and seamless transition between different stages of a DMTA cycle thereby reducing timelines for early drug discovery.
Driving operational excellence with SQDECC
SQDECC is an industry-recognized model that enables the operational teams to get a unified view of their efficiency across parameters of Safety, Quality, Delivery, Engagement, Cost, and Compliance (SQDECC).
Achieving Biologics manufacturing milestones using a systemic approach to Technology Transfer
Learn how Syngene achieves manufacturing milestones in Biologics using a systemic approach to 100% ‘first-time right’ technology transfer.
Building resilience in Supply Chain Management – the Syngene way
Syngene has a well-defined system that delivers across all aspects of Supply Chain Management, ranging from planning and inventory to sourcing, procurement, logistics, performance, safety, and compliance.
How Organocatalysis discovered by Nobel laureates revolutionised drug development and production in Syngene
David Macmillan and Benjamin List are joint Nobel prize winners for 2021 in chemistry for their ground-breaking work on the development of asymmetric organocatalysis. The efficacy of organocatalysis in asymmetric synthesis has influenced the field of organic synthesis since the early 2000s. Recognising this powerful science, the Discovery Chemistry team at Syngene has transitioned from […]
Comprehensive solutions for clinical development of generic drugs
Synene has developed more than 100 assays for conducting BA/BE studies across small and large molecules.
In silico toxicity prediction using Derek Nexus for predicting skin sensitization, phototoxicity, hepatotoxicity and in vitro hERG inhib
In silico toxicity evaluation using Derek® Nexus for quicker and cost-effective screening for skin sensitization phototoxicity, hepatotoxicity, and in vitro hERG channel inhibition
<br>Chromatography based purification of retro virus spikes
Presenting the data for purification of Retro virus using ion exchange chromatography where the condition for purification was optimized.